News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,623 Results
Type
Article (52616)
Company Profile (709)
Press Release (675298)
Section
Business (210963)
Career Advice (3359)
Deals (37447)
Drug Delivery (107)
Drug Development (84696)
Employer Resources (183)
FDA (16970)
Job Trends (16218)
News (360315)
Policy (34619)
Tag
Academia (2777)
Alliances (51545)
Alzheimer's disease (1308)
Approvals (16867)
Artificial intelligence (136)
Bankruptcy (377)
Best Places to Work (12152)
Biotechnology (488)
Breast cancer (121)
Cancer (1047)
Career advice (2834)
Cell therapy (242)
Clinical research (66800)
Collaboration (366)
Compensation (175)
COVID-19 (2718)
C-suite (95)
Data (962)
Diabetes (155)
Diagnostics (6532)
Drug pricing (94)
Earnings (83690)
Employer resources (158)
Events (119090)
Executive appointments (270)
FDA (17444)
Funding (321)
Gene therapy (176)
GLP-1 (664)
Government (4627)
Healthcare (19768)
Infectious disease (2801)
Inflammatory bowel disease (115)
Interviews (658)
IPO (17243)
Job creations (4457)
Job search strategy (2329)
Layoffs (476)
Legal (8318)
Lung cancer (174)
Manufacturing (182)
Medical device (14119)
Medtech (14124)
Mergers & acquisitions (20226)
Metabolic disorders (430)
Neuroscience (1577)
NextGen Class of 2024 (7256)
Non-profit (4560)
Northern California (1341)
Obesity (253)
Opinion (238)
Patents (102)
People (59867)
Pharmaceutical (137)
Phase I (20838)
Phase II (29439)
Phase III (22112)
Pipeline (327)
Postmarket research (2533)
Preclinical (8870)
Radiopharmaceuticals (256)
Rare diseases (213)
Real estate (6520)
Regulatory (23001)
Research institute (2488)
Resumes & cover letters (536)
Southern California (1199)
Startups (4034)
United States (13193)
Vaccines (630)
Weight loss (203)
Date
Last 7 days (1109)
Last 30 days (3319)
Last 365 days (37760)
2024 (33339)
2023 (42211)
2022 (53469)
2021 (58054)
2020 (56515)
2019 (49467)
2018 (37632)
2017 (35501)
2016 (35418)
2015 (41159)
2014 (34187)
2013 (28883)
2012 (30578)
2011 (30905)
2010 (28597)
Location
Africa (976)
Arizona (169)
Asia (43464)
Australia (7305)
California (3129)
Canada (1226)
China (235)
Colorado (138)
Connecticut (147)
Europe (96889)
Florida (428)
Georgia (114)
Illinois (372)
Indiana (205)
Kansas (98)
Maryland (559)
Massachusetts (2611)
Michigan (165)
Minnesota (278)
New Jersey (915)
New York (916)
North Carolina (800)
Northern California (1341)
Ohio (135)
Pennsylvania (799)
South America (1355)
Southern California (1199)
Texas (443)
Washington State (372)
728,623 Results for "the emmes company llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
ILiAD Biotechnologies Announces Planned Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, to Conduct Upcoming Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine
ILiAD Biotechnologies, LLC today announced the selection of Emmes Group, a global contract research and technology organization, to conduct upcoming Phase III studies of its lead pertussis vaccine candidate, BPZE1. ILiAD and Emmes Group are currently working to finalize the definitive agreement.
June 24, 2024
·
4 min read
Business
Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.
Scilex Holding Company announced that in anticipation of selling our commercially available products to new and current special customers, Scilex has entered into a non-exclusive distribution agreement with a well-known and highly respected distributor with over 10 years of sales excellence, Endeavor Distribution LLC.
June 20, 2024
·
7 min read
Press Releases
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network
September 4, 2024
·
2 min read
Emmes Acquires VaxTRIALS
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation
October 5, 2023
·
3 min read
Press Releases
Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients
October 23, 2024
·
2 min read
Press Releases
Prime Therapeutics LLC earns certification from the National Committee for Quality Assurance
October 3, 2024
·
2 min read
Genetown
Strategic Acquisition Opportunity: Biotechnology Intellectual Property of Civetta Therapeutics, LLC Now Open for Bids
The Assignee of Civetta Therapeutics, LLC, a trailblazer in the field of biotechnology with a focus on β-propeller protein research, is inviting bids for the company’s rich portfolio of intellectual property.
April 4, 2024
·
2 min read
Deals
INTEGRATED ONCOLOGY NETWORK ANNOUNCES THE ACQUISITION OF UROLOGY PARTNERS, LLC
Integrated Oncology Network, LLC (“ION”), a portfolio company of Silver Oak Services Partners, LLC (“Silver Oak”), today announced the acquisition of Urology Partners, LLC.
May 2, 2024
·
3 min read
FDA
Grace Science, LLC Selected by FDA to Participate in the START Pilot Program for GS-100 Gene Therapy for NGLY1 Deficiency and Announcement of the Successful Treatment of the 2nd Patient
Grace Science, LLC announced today that the IND for GS-100, an AAV9 gene therapy for NGLY1 Deficiency, was accepted into the FDA’s Support for clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program.
June 3, 2024
·
3 min read
Press Releases
Zevra Therapeutics to Participate in Rare Disease Panel at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
October 10, 2024
·
2 min read
1 of 72,863
Next
